Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 350 of 1294 entries
View as:

Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation

Phase: N/A Priority: Normal
NCT ID: NCT01697644 Org: User:
Start: 10/31/90 End: 05/31/05 Due: 05/31/06

Comparison of Repaglinide and Gliclazide in Chinese Subjects With Type 2 Diabetes Never Received Oral Antidiabetic Drug Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01022762 Org: User:
Start: 11/30/09 End: 11/30/10 Due: 11/30/11

An Observational Study of Insulin Aspart and, if Necessary, Insulin Levemir (FlexPen®) in the Evening or at Bedtime

Phase: N/A Priority: Normal
NCT ID: NCT01487421 Org: User:
Start: 07/31/03 End: 10/31/06 Due: 10/31/07

Evaluation of Safety Following Immune Tolerance Induction Treatment With Turoctocog Alfa in Patients With Haemophilia A Following Inhibitor Development in NN7170-4213 Trial

Phase: N/A Priority: Normal
NCT ID: NCT03588741 Org: User:
Start: 06/12/18 End: 06/19/19 Due: 06/19/20

Safety of 40K Pegylated Recombinant Factor IX in Non-Bleeding Patients With Haemophilia B

Phase: N/A Priority: Normal
NCT ID: NCT00956345 Org: User:
Start: 08/31/09 End: 07/31/10 Due: 07/31/11

Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B

Phase: N/A Priority: Normal
NCT ID: NCT01386528 Org: User:
Start: 06/07/12 End: 12/01/13 Due: 12/01/14

Observational Study of Glycaemic Control in Patients Uncontrolled on Oral Antidiabetic Agents and Starting With 1 (Once) Daily Levemir® (Insulin Detemir) as the Treatment of Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00687284 Org: User:
Start: 02/29/08 End: 06/30/10 Due: 06/30/11

A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin

Phase: N/A Priority: Normal
NCT ID: NCT01435629 Org: User:
Start: 11/22/12 End: 12/04/15 Due: 12/04/16

Comparison of Two Vaginal Tablets, Produced at Different Sites, in Postmenopausal Women With Atrophic Vaginitis

Phase: N/A Priority: Normal
NCT ID: NCT01085877 Org: User:
Start: 03/31/10 End: 05/31/10 Due: 05/31/11

Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01336023 Org: User:
Start: 05/23/11 End: 11/22/12 Due: 11/22/13

Switch From Metformin Monotherapy to a Bitherapy With Metformin and Repaglinide

Phase: N/A Priority: Normal
NCT ID: NCT00745433 Org: User:
Start: 01/31/08 End: 03/31/09 Due: 03/31/10

A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification

Phase: N/A Priority: Normal
NCT ID: NCT02100475 Org: User:
Start: 04/30/14 End: 04/30/15 Due: 04/30/16

Safety and Efficacy of Turoctocog Alfa in Previously Treated Male Children With Haemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT01138501 Org: User:
Start: 06/30/10 End: 11/30/11 Due: 11/30/12

Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02128932 Org: User:
Start: 08/04/14 End: 09/03/15 Due: 09/03/16

Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine

Phase: N/A Priority: Normal
NCT ID: NCT01680341 Org: User:
Start: 08/31/12 End: 08/22/13 Due: 08/22/14

A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

Phase: N/A Priority: Normal
NCT ID: NCT02205528 Org: User:
Start: 08/18/14 End: 09/15/15 Due: 09/15/16

Safety and Tolerability of NN9068 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00983021 Org: User:
Start: 09/30/09 End: 12/31/09 Due: 12/31/10

A Research Study to Compare How Much of the Medicine NNC0519-0130 is in the Blood of People With Overweight or Obesity Who Receive 2 Preparations of the Medicine

Phase: N/A Priority: Normal
NCT ID: NCT06642571 Org: User:
Start: 10/15/24 End: 05/31/25 Due: 05/31/26

A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03989232 Org: User:
Start: 06/19/19 End: 11/09/20 Due: 11/09/21

Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01527643 Org: User:
Start: 11/11/03 End: 12/17/03 Due: 12/17/04

Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-HERO-S)

Phase: N/A Priority: Normal
NCT ID: NCT02568202 Org: User:
Start: 09/30/15 End: 11/30/15 Due: 11/30/16

A Trial to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Oral Semaglutide in Healthy Male Japanese and Caucasian Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02161588 Org: User:
Start: 06/30/14 End: 11/30/14 Due: 11/30/15

Observational Study to Evaluate the Safety While Using Levemir®

Phase: N/A Priority: Normal
NCT ID: NCT00701155 Org: User:
Start: 07/31/07 End: 03/31/08 Due: 03/31/09

Investigating the Pharmacokinetics, Safety and Tolerability After a Single Subcutaneous Injection of Semaglutide in Subjects With Mild, Moderate or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT02210871 Org: User:
Start: 08/07/14 End: 06/03/15 Due: 06/03/16

An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry

Phase: N/A Priority: Normal
NCT ID: NCT01892319 Org: User:
Start: 09/30/13 End: 09/30/19 Due: 09/30/20